Dr Fred Klenner MD – The Treatment of Poliomyelitis and Other Virus Diseases with Vitamin C




The Treatment of Poliomyelitis and Other Virus Diseases with Vitamin C Fred R.<br /> Klenner, M.D. 1949

Reidsville, North Carolina

Southern Medicine & Surgery, Volume 111, Number 7, July, 1949, pp. 209-214

IN A PREVIOUS REPORT dealing with the antagonistic properties of ascorbic acid to the
virus of atypical pneumonia, mention was made of the fact that other types of virus
infections had responded favorably to vitamin C. This paper is to present these findings
as well as the results of subsequent studies on the virus of poliomyelitis, the viruses
causing measles, mumps, chickenpox, herpes zoster, herpes simplex and influenza. Further
studies with the virus of atypical pneumonia will also be discussed.

These observations of the action of ascorbic acid on virus diseases were made
independently of any knowledge of previous studies using vitamin C on virus pathology,
except for the negative report of Sabin after treating Rhesus monkeys experimentally
infected with the poliomyelitis virus. A review of the literature in preparation of this
paper, however, presented an almost unbelievable record of such studies. The years of
labor in animal experimentations; the cost in human effort and in “grants,” and
the volumes written, make it difficult to understand how so many investigators could have
failed in comprehending the one thing that would have given positive results a decade ago.
This one thing was the size of the dose of vitamin C employed and the frequency of its
administration. In all fairness it must be said that Jungeblut noted on several occasions
that he attributed his failure of results to the possibility that the strength of his
injectable “C” was inadequate. It was he who unequivocally said that
“vitamin C can truthfully be designated as the antitoxic and antiviral vitamin.”

In developing this paper it was felt that, since all virus infections were more or less
akin, only one of this family would be considered in detail. Poliomyelitis, because of its
prevalence and the seriousness of the problem it presents, was chosen as the disease to be
so treated.


Poliomyelitis is in most instances an acute febrile disease of sudden onset, with
symptoms of a systemic infection which either abruptly abort or develop to hyperesthesia,
asymmetry of reflexes and flaccid paralysis or palsies of muscle groups. It affects
individuals of all ages, but mainly children, as do more common childhood diseases to
which class it most likely belongs. Only slight contact between the carrier of the virus
and the susceptible person suffices in some cases for the transfer of the causative
organism. In this respect and also in that the virus can be demonstrated in the nasal
washings as early as six days before onset of symptoms, poliomyelitis resembles measles.
We never have an epidemic of poliomyelitis preceding an epidemic of measles; the opposite
is frequently true. This grouping of the virus organisms is too often repeated not to
carry some significance. For example, atypical pneumonia and influenza are caused by
closely allied viruses; so are chickenpox, herpes zoster and herpes simplex; so are
measles, mumps and poliomyelitis. The incubation period depends on the mode of entry. In
experimental animals. Fraser and others showed that the average was 6.6 days with
intracerebral inoculation and ten days when the intravenous route was used. Howitt
mentions that the virus reaches the nervous system sooner after intranasal than after
intravenous instillations. Transmission (Brodie, 1934) is by means of droplets from the
mucous membrane of the upper respiratory tract. Infection by means of raw milk, human
feces and house feces is highly improbable.

The research of Flexner, Clark and Amoss in 1914 proved that poliomyelitis is a disease
of the entire nervous system, that the sensory ganglia are the seats of early and profound
histological changes. The disease is significant mainly for the paralysis produced through
injury to the motor neurons of the spinal cord and brain. This is caused by a special
affinity of the virus for a certain type of nerve tissue. Experiments show the cerebral
cortex to be the most unsatisfactory site for growth, that large amounts of the virus
placed in this area are apt to disappear in a short time. Observations in monkeys and in
man show that the anterior horn cells, particularly those of the lumbar cord, are the most
favorable sites for proliferation of the virus.

In all clinically ill patients the virus eventually travels in the course of its
invasion by several channels. The virus can make a direct assault through the olfactory
bulb, to the brain, medulla and spinal cord. The virus can enter the blood stream directly
or through the lymph channels. Following damage to the natural protective barrier, the
choroid plexus, it can make its way to the central nervous system, or it can be excreted
back onto the nasal mucous membrane where it will pick up the direct route of the
olfactory bulb.

Clark, Turner and Reynolds (1926, 1927, 1929) concluded that the virus chiefly travels
by the direct route to the brain. Lenten and Hudson (1935) confirmed this theory and
reported their studies indicating that human infection is chiefly through the nasopharynx.
Brodi and others showed that by section of the olfactory tracts in monkeys infection by
the direct route was prevented. It is of more than mere academic interest that while the
nasal mucous of the monkey contains branches of the 5th and 7th cranial nerves and that in
addition, since the virus can readily gravitate from the nasopharynx to the tonsil bed
with its nerve supply, if the olfactory tracts are cut no infection will occur. The
most likely explanation is that the olfactory is non-medullated, the neurones lie in the
nasal mucosa and are thus exposed to the virus. The sciatic nerve (Brodi) will transport
the virus only when it has been injured, suggesting that lack of myelin may render the
healthy olfactory nerve vulnerable to the virus.

The most important of the secondary routes at infection is by the excretion of the
virus from the blood stream onto the nasal mucosa. Lenten and Hudson (1934, 1935)
demonstrated in monkeys that by sectioning the olfactory tracts and then inoculating by
the intravenous route with the virus of poliomyelitis, they could prevent infection.

This would fit in with the work of Jungeblut and others that the spread of the virus
through the central nervous system is along nerve tracts, rather than by means of the
cerebrospinal fluid, the infection to become manifest when the first cell group is
reached, and by relays of fibers, reaches the midbrain. Here numerous fiber-paths run in
all directions and the virus is carried by both motor and sensory axons, causing disease
at many levels of the brain and cord.

Since there is always a period of septicemia in the first few days of poliomyelitis, it
might be that this is the all-important route and that the virus is grown on a living
tissue, the blood, and then is deposited out on the surface of the olfactory bulb. From
this we conclude that the time to destroy the virus is during this incubation period which
varies more with virulence and power of multiplication than with size of initial dose.

The second flanking maneuver of importance is through the choroid plexus. It is the
function of the choroid plexus and the pial lymphatic vessels to exclude the virus present
in the blood from the nervous system. Once these protective structures are injured,
however, the exclusion ceases and infection can follow readily. Changes in the structure
or function of the meningeal choroid plexus complex, too slight to be detected in the
cerebrospinal fluid or as morphological alterations, materially diminish its protective
power. Flexner and Amoss injected large doses of the virus intravenously, then tested the
cerebrospinal fluid and found no virus after the first 48 hours; virus in small amounts at
the end of 72 hours; after 96 hours evidence of free access to this system. The virus was
still present 19 days later when paralysis was beginning.

Poliomyelitis in man is always more severe if exercise is taken at time of the
infection. Here one must consider the factor of filtration of the virus through the
choroid plexus as being increased due to the elevation of the vascular bed pressure. Also,
that, by the acceleration of the blood flow caused by greater oxygen demand in physical
effort, a marked increase in the percentage of the virus deposited on the nasal mucosa
would result.

We must agree with Fairbrother and Hurst that too little consideration has been given
to the pathology of the nervous system and in particular to the drainage of the tissue
fluids. These men confirmed the earlier work of Schroder, who stressed that the normal
flow of these fluids is along the perivascular spaces from the center of the cord outward,
and that any inflammatory exudate occupying these spaces must be swept into the pial
meshes; further that meningeal infiltration may seem nothing more than a drainage of cells
from the interior of the cord. Fairbrother and Hurst found that meningeal infiltration
does not occur in monkeys until the perivascular infiltration beginning in the deeper
vessels reaches the surface.

The presence of the filterable microorganism or virus of poliomyelitis upon the mucous
membrane of the nose and throat does not necessarily lead to infection. It may give rise
to a class of healthy carriers who are themselves immune. Amoss and Taylor found a
secretion of the mucous membrane capable of neutralizing or inactivating the virus, this
property absent altogether from the secretions of some persons, in those of others present
at one time and not at another. It is probable that in actively immune animals the passage
of the neutralizing substance from the blood into the cerebrospinal fluid would continue
as long as the inflammation present in the meninges rendered the structures easily
permeable to the protein constituents of the blood. This secretion X could not have
the properties of a true antibody. The virus of poliomyelitis is intracellular from the
time it invades the terminal cells of the olfactory system until the end of the disease,
except when crossing the synaptic junctions between cells. This explains why the virus
cannot be neutralized by antibodies in the serum. Further protection is afforded the virus
by the functional barrier between the circulating blood and the central nervous system.


Since immunization against poliomyelitis comparable to that against other bacterial
diseases is still a matter of the future, it suggested itself that some antibiotic could
be found that would destroy this scourge while in the phase of blood-stream invasion.
Sabin’s negative report on the value of ascorbic acid on the poliomyelitis virus
stopped Jungeblut’s work, but we were cognizant of its dramatic effect on the virus
causing atypical pneumonia, and so kept up hope. These results were so consistently
positive that we did not hesitate to try its effectiveness against all types of virus
infections. The frequent administration of massive doses of vitamin C was so encouraging
in the early days of the 1948 epidemic of poliomyelitis that a review of the literature
was begun.

Heaslip, in the Australian Journal of Experimental Biology & Medicine reported
a mean urinary output of vitamin C under a load test of 19.9 per cent in 60 poliomyelitis
cases, as contrasted with a mean figure of 44.3 per cent in 45 healthy contacts. This was
suggestive of some relationship between the degree of vitamin C saturation and the
infectious and noninfectious state. He was also able to show a correlation between the
severity of the attack and the level of urinary excretion of the vitamin. This would
indicate that a deficiency of vitamin C in the diet predisposed to infection and to
severity of attack. Sabin reported no appreciable difference in infectivity of
poliomyelitis in monkeys with much or no vitamin C in the diet. Many others, however, have
reported that a “deficient vitamin C nutrition increases susceptibility to
infection,” and many others that animals dying from the effects of the poliomyelitis
virus show a reduction of vitamin C in the tissues. Heaslip found a definite relationship
between the severity of the infection and the level of vitamin C nutrition. It is
consistent with accepted physiological action of vitamin C to expect an anti-edema effect
in any given affected area. It is worthy of note that bacterial toxins can cause losses of
from 50 to 85 per cent of the vitamin C normally contained in the adrenals.

Jungeblut’s investigations seemed to justify the conclusion that vitamin C was the
“antibiotic” that would destroy the virus organism. He stated that the
prophylactic and therapeutic administration of synthetic or natural vitamin C had given
evidence of having distinct therapeutic properties in experimental poliomyelitis, and that
the proper injection dose was directly proportional to the speed of the infection and the
stage at which the process had arrived. Jungeblut stated in 1937 that the parenteral
administration of natural vitamin C during the incubation period of poliomyelitis in
monkeys is always followed by a distinct change in the severity of the disease; that after
the fifth day of the disease distinctly larger doses are required. He realized, at that
early date, that for a fast progressing infection such as results from the
R. M. V. strain, very large doses — 400 mg. crystalline C maximum in a
24-hour period — of vitamin C would be required; for the Aycock virus with its slower
infection potential small amounts of the vitamin would suffice. Even with almost
infinitesimal amounts — 100 mg. ascorbic acid for each 24-hour period — he was
able to demonstrate that the non-paralytic survivors in one series was six times as great
as in the controls. In our work we shall speak of six, ten and 20 thousand mg. in a
similar time period.

Harde et al. reported that diphtheria toxin is inactivated by vitamin C in vitro and to
a lesser extent in vivo. I have confirmed this finding, indeed extended it. Diphtheria can
be cured in man by the administration of massive frequent doses if hexuronic acid (vitamin
C) given intravenously and/or intramuscularly. To the synthetic drug, by mouth, there is
little response, even when 1000 to 2000 mg. is used every two hours. This cure in
diphtheria is brought about in half the time required to remove the membrane and give
negative smears by antitoxin. This membrane is removed by lysis when “C” is
given, rather than by sloughing as results with the use of the antitoxin. An advantage of
this form of therapy is that the danger of serum reaction is eliminated. The only
disadvantage of the ascorbic acid therapy is the inconvenience of the multiple injections.
This concept of the action of vitamin C against certain toxins has led to treating other
diseases producing exotoxins. For years it has been our knowledge that vitamin C in 500 to
1000 mg. doses injected I. M. would cure bacillary dysentery of the Shiga type.
Children having 10 to 15 bloody stools per day have cleared in 48 hours under this
schedule while at the same time reverting to normal feedings.

This dual action of vitamin C against certain toxins and the virus organism becomes
more intelligible with the work of Kligler, Warburg and others who believed that the
detoxication effected by hexuronic acid is brought about by a direct combination of the
vitamin with the toxin or virus, this followed by oxidation of the new compound which
destroys both the virus or toxin and the vitamin. Borsook et al. decided that the main
chemical action of ascorbic acid is as a powerful reducing agent, and the virus causing
poliomyelitis is known to be susceptible to the oxidizing action of various agents. It is
in point here to remark that vitamin C is an integral part of the oxidation-reduction
system of the body, thus playing a definite part in natural resistance.


In the poliomyelitis epidemic in North Carolina in 1948, 60 cases of this disease came
under our care. These patients presented all or almost all of these signs and symptoms:
Fever of 101 to 104.6°, headache, pain at the back of the eyes, conjunctivitis, scarlet
throat; pain between the shoulders, the back of the neck, one or more extremity, the
lumbar back; nausea, vomiting and constipation. In 15 of these cases the diagnosis was
confirmed by lumbar puncture; the cell count ranging from 33 to 125. Eight had been in
contact with a proven case; two of this group received spinal taps. Examination of the
spinal fluid was not carried out in others for the reasons: (1) Flexner and Amoss had
warned that “simple lumbar puncture attended with even very slight hemorrhage opens
the way for the passage of the virus from the blood into the central nervous system and
thus promotes infection.” (2) A patient presenting all or almost all of the above
signs and symptoms during an epidemic of poliomyelitis must be considered infected with
this virus. (3) Routine lumbar puncture would have made it obligatory to report each case
as diagnosed to the health authorities. This would have deprived myself of valuable
clinical material and the patients of most valuable therapy, since they would have been
removed to a receiving center in a nearby town.

The treatment employed was vitamin C in massive doses. It was given like any other
antibiotic every two to four hours. The initial dose was 1000 to 2000 mg., depending on
age. Children up to four years received the injections intramuscularly. Since laboratory
facilitates for whole blood and urine determinations of the concentration of vitamin C
were not available, the temperature curve was adopted as the guide for additional
medication. The rectal temperature was recorded every two hours. No temperature response
after the second hour was taken to indicate the second 1000 or 2000 mg. If there was a
drop in fever after two hours, two more hours was allowed before the second dose. This
schedule was followed for 24 hours. After this time the fever was consistently down, so
the drug was given 1000 to 2000 mg. every six hours for the next 48 hours. All patients
were clinically well after 72 hours. After three patients had a relapse the drug was
continued for at least 48 hours longer — 1000 to 2000 mg. every eight to 12 hours.
Where spinal taps were performed, it was the rule to find a reversion of the fluid to
normal after the second day of treatment.

For patients treated in the home the dose schedule was 2000 mg. by needle every six
hours, supplemented by 1000 to 2000 mg. every two hours by mouth. The tablet was crushed
and dissolved in fruit juice. All of the natural “C” in fruit juice is taken up
by the body; this made us expect catalytic action from this medium. Rutin, 20 mg., was
used with vitamin C by mouth in a few cases, instead of the fruit juice. Hawley and others
have shown that vitamin C taken by mouth will show its peak of excretion in the urine in
from four to six hours. Intravenous administration produces this peak in from one to three
hours. By this route, however, the concentration in the blood is raised so suddenly that a
transitory overflow into the urine results before the tissues are saturated. Some
authorities suggest that the subcutaneous method is the most conservative in terms of
vitamin C loss, but this factor is overwhelmingly neutralized by the factor of pain
inflicted.

Two patients in this series of 60 regurgitated fluid through the nose. This was
interpreted as representing the dangerous bulbar type. For a patient in this category
postural drainage, oxygen administration, in some cases tracheotomy, needs to be
instituted, until the vitamin C has had sufficient time to work — in our experience
36 hours. Failure to recognize this factor might sacrifice the chance of recovery. With
these precautions taken, every patient of this series recovered uneventfully within three
to five days.

In the treatment of other types of virus infections the same “fluid” dose
schedule was adopted.  In herpes zoster 2000 to 3000 mg. of vitamin C was given every
12 hours, this supplemented by 1000 mg. in fruit juice by mouth every two hours. Eight
cases were treated in this series, all of adults. Seven experienced cessation of pain
within two hours of the first injection and remained so without the use of any other
analgesic medication. Seven of these cases showed drying of the vesicles within 24 hours
and were clear of lesions within 72 hours. They received from five to seven injections.
One patient, a diabetic, stated that she was always conscious of an uncomfortable feeling,
but that it was not an actual pain. Although nine-tenths of the vesicles cleared in the
usual 72-hour period, she was given 14 injections, the last seven of only 1000 mg. This
extra therapy was given because of a small ulceration, an inch in diameter, secondarily
infected by rupture of the vesicles by a corset stave prior to the first visit. Vitamin C
apparently had no effect on this lesion, which was healed in two weeks under compound
tincture of benzoin locally and penicillin and sulfadiazine by mouth. (The patient
objected to taking penicillin by needle.) One of the patients, a man of 65, came to the
office doubled up with abdominal pain and with a history of having taken opiates for the
preceding 36 hours. He gave the impression of having an acute surgical condition. A
massive array of vesicles extended from the dorsal nerve roots to the umbilicus, a
hand’s breadth wide. He was given 3000 mg. of vitamin C intravenously and directed to
return to the office in four to five hours. It was difficult to convince him that his
abdominal pain was the result of his having “shingles.” He returned in four
hours completely free of pain. He was given an additional 2000 mg. of vitamin C, and
following the schedule given above he recovered completely in three days.

In herpes simplex it is important to continue the treatment for at least 72 hours. We
have seen “fever blisters” that appeared healed after two infections recur when
therapy was discontinued after 24 hours. Vitamin C in a strength of 1000 mg. per 10 c.c.
of buffered solution gave no response when applied locally. This was true no matter how
often the applications were made. In several cases 10 mg. of riboflavin by mouth t.i.d. in
conjunction with the vitamin C injections appeared to cause faster healing.

Chickenpox gave equally good response, the vesicles responding in the same manner as
did those of herpes. These vesicles were crusted after the first 24 hours, and the patient
well in three to four days. We interpreted this similarity of response in these three
diseases to suggest that the viruses responsible were closely related to one another.

Many cases of influenza were treated with vitamin C. The size of the dose and the
number of injections required were in direct proportion to the fever curve and to the
duration of the illness. Forcing of fruit juice was always recommended, because of the
frequency and ease of reinfection during certain periods of the year.

The response of virus encephalitis to ascorbic acid therapy was dramatic. Six cases of
virus encephalitis were treated and cured with vitamin C injections. Two cases were
associated with virus pneumonia; one followed chickenpox, one mumps, one measles and one a
combination of measles and mumps. In the case that followed the measles-mumps complex,
definite evidence was found to confirm the belief that massive, frequent injections are
necessary in treating virus infections with vitamin C. This lad of eight years was first
seen with a temperature of 104°. He was lethargic, very irritable when molested. His
mother said he had gradually developed his present clinical picture over the preceding
four or five days. His first symptom was anorexia which became complete 36 hours before
his first examination. He next complained of a generalized headache, later he became
stuporous. Although very athletic and active, he voluntarily took to his bed. He was given
2000 mg. of vitamin C intravenously and allowed to return home because there were no
available hospital accommodations. His mother was asked to make an hourly memorandum of
his conduct until his visit set for the following day. Seen 18 hours after the initial
injection of vitamin C, the memorandum revealed a quick response to the antibiotic —
after two hours be asked for food and ate a hearty supper, then played about the house as
usual and then, for several hours, he appeared to have completely recovered. Six hours
following the initial injection, he began to revert to the condition of his first visit.
When seen the second time temperature was 101.6°, he was sleepy but he would respond to
questions. The rude irritability shown prior to the first injection was strikingly absent.
A second injection of 2000 mg. vitamin C was given intravenously and 1000 mg. of
“C” prescribed every two hours by mouth. The next day he was fever-and
symptom-free. As a precautionary measure a third 2000 mg. was given with direction to
continue the drug by mouth for at least 48 hours. He has remained well since. A lad of 12
years had generalized headache a week after having mumps, this followed by malaise, and in
12 hours a lethargic state and a fever of 105°. Admitted to hospital he was given 2000
mg. of vitamin C then, and 1000 mg. every two hours. Following the third injection he. was
sitting up in bed, laughing, talking, begging for food and completely without pain. He was
discharged 24 hours following admission clinically well. Since relapses do occur if the
drug is discontinued too soon, he was given 2000 mg. of vitamin C every 12 hours for two
additional days.

The use of vitamin C in measles proved to be a medical curiosity. During an epidemic
vitamin C was used prophylactically and all those who received as much as 1000 mg. every
six hours, by vein or muscle, were protected from the virus. Given by mouth, 1000 mg. in
fruit juice every two hours was not protective unless it was given around the clock. It
was further found that 1000 mg. by mouth, four to six times each day, would modify the
attack; with the appearance of Koplik’s spots and fever, if the administration was
increased to 12 doses each 24 hours, all signs and symptoms would disappear in 48 hours.
If the drug was discontinued or reduced to three or four doses each 24 hours following the
disappearance of Koplik’s spots, within another 48-hour period the fever, the
conjunctivitis and Koplik’s spots would be back.

It was our privilege to observe this picture over and over in two little volunteer
girls for 30 days. These “research helpers” were my own little daughters. The
measles virus was eventually destroyed in this instance by continuing 12,000 mg. by mouth
each 24 hours for four days. We interpreted this result to indicate that on withdrawing
the drug with the cessation of signs and symptoms, a small quantity of the virus remained,
which after another incubation period produced anew the first stage of measles; when the
drug was continued beyond the clearing stage the virus was destroyed in toto. No case of
post-measles bronchopneumonia was seen. The “measles-cough” of measles
bronchitis was over with after three or four 1000 mg. injections of “C” at
6-hour intervals. This was true even when other medications well above the calculated dose
range for cough had had no effect. Whenever a patient presented a mixed-virus infection,
such as receding mumps and developing measles, it was found that double the calculated
dose of vitamin C was necessary to obtain the usual results.

Of mumps, 33 cases were treated with ascorbic acid. When vitamin C was given at the
peak of the infection the fever was gone within 24 hours, the pain within 36 hours, the
swelling in 48 to 72 hours. Two cases were complicated with orchitis. A young man of 23
years developed bilateral orchitis one Friday morning, by seven o’clock that night he
was in severe pain, had a fever of 105° and was nursing testicles the size of tennis
balls. Vitamin C was started at this time — 1000 mg. every two hours, intravenously.
The pain began to subside following the first injection and ceased in 12 hours. There was
no fever after 36 hours. The patient was out of bed feeling his old self after 60 hours.
He had received 25,000 mg. of “C” in this 60-hour period. An experiment
involving three cousins: One, a boy of seven, had the old routine of bed rest, aspirin,
and warm camphor oil applications and iodex to the swollen glands. This child had a rough
time for a week. A second boy, aged 11, was allowed to develop mumps to the point of
maximum swelling without any therapy, then given vitamin C, 1000 mg. intramuscularly,
every two to four hours. This lad was entirely well in 48 hours. To the third patient, a
girl of 9, vitamin C was given on the up curve when the swellings were 60 per cent of the
expected, and the temperature recorded at 102.3°. The dose was 1000 mg. of vitamin C
given intravenously every four hours. This child was well and remained so from the third
day of treatment.

Further studies on virus pneumonia showed that the clinical response was better when
vitamin C was given to these patients according to the dose schedule outlined for
poliomyelitis. Where pneumonitis was demonstrated, the clearing of the chest film was
parallel with the clinical recovery. In cases of consolidation of entire lobes the x-ray
clearing lagged days behind the clinical response. In these cases 1000 mg. of
“C” should be given every 12 hours for at least a week after the patient is
apparently well. There was no change in the results as given in a previous paper; the
patients were well in the third day of treatment.


In using vitamin C as an antibiotic no factor of toxicity
need be considered. To confirm this observation 200 consecutive hospital patients were
given ascorbic acid, 500 to 1000 mg. every four to six hours, for five to ten days. One
volunteer received 100,000 mg. in a 12-day period. It must be remembered that 90 per cent
of these patients did not have a virus infection to assist in destroying the vitamin. In
no instance did examination of the blood or urine indicate any toxic reaction, and at no
time were there any clinical manifestations of a reaction to the drug. When vitamin C was
given by mouth one per cent of these patients vomited shortly after taking the drug. In
half of these cases the vomiting was controlled by increasing the carbohydrate content of
the mixture. This reaction was not interpreted as representing a toxic manifestation;
rather it was thought to be due to a hypersensitive gastric mucosa. The dose was reduced
from 1000 to 100 mg. in young children showing this complex; vomiting occurred as before.
However, in these same patients administration of massive, frequent doses of vitamin C by
needle effected a cure of the infection without causing vomiting.

From a review of the literature one can safely state that in all instances of
experimental work with ascorbic acid on the virus organism the amount of virus used was
beyond the range of the administered dose of this vitamin. No one would expect to relieve
kidney colic with a five-grain aspirin tablet; by the same logic we cannot hope to destroy
the virus organism with doses of vitamin C of 10 to 400 mg. The results which we have
reported in virus diseases using vitamin C as the antibiotic may seem fantastic. These
results, however, are no different from the results we see when administering the sulfa,
or the mold-derived drugs against many other kinds of infections. In these latter
instances we expect and usually get 48- to 72-hour cures; it is laying no claim to
miracle-working then, when we say that many virus infections can be cleared within a
similar time limit.


REFERENCES

  1. Sabin, 19??
  2. Jungeblut, 19??
  3. Fraser, 19??
  4. Howitt, 19??
  5. Brodie, 1934
  6. Flexner, Clark and Amoss, 1914
  7. Clark, Turner and Reynolds, 1926, 1927, 1929
  8. Lenten and Hudson, 1934, 1935
  9. Fairbrother and Hurst, 19??
  10. Amoss and Taylor, 19??
  11. Heaslip, 19??
  12. Jungeblut, 1937
  13. Harde, 19??
  14. Kligler, 19??
  15. Warburg, 19??
  16. Borsook, 19??
  17. Hawley, 19??

IMPORTANT:  Information provided is intended for educational purposes and is not intended to be medical advice nor offered as a prescription, diagnosis or treatment for any disease, illness, infirmity or physical condition. Always consult your own medical provider about your health and medical questions before making any health related decision. These statements have not been evaluated by the Food & Drug Administration.